TOP TIERMARKET NEWSWIRE
Movers explained · November 20, 2026

Why Is GENMAB A/S ADR (GMAB) Stock Moving Today?

By the Top Tier Newswire AI Desk · October 29, 2026 at 12:00 AM ET · reviewed against 1 wire stories

GENMAB A/S ADR (GMAB) is drawing unusual attention today. Our newswire has captured 1 story on GMAB across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 74/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

Genmab A/S ADR (GMAB) shares surged 28.25% to $57.29 on Wednesday. The primary driver was the announcement of positive Phase III clinical trial results for its head and neck cancer treatment, Petosemtamab, which demonstrated a significant reduction in mortality risk when combined with Merck’s Keytruda.

What Happened

Genmab reported that Petosemtamab, when used in combination with Keytruda, reduced the risk of death by 50% compared to Keytruda alone. This clinical update highlighted potential new treatment standards for the disease. The stock closed at an all-time high, reflecting strong investor confidence in the medical research progress. While AlphaValue/Baader Europe recently downgraded the stock to Reduce, the market response to the trial data was overwhelmingly positive. The company discussed these Phase III cancer data points in a transcript dated October 28, 2026.

What The Data Shows

The stock’s market capitalization stands at $26.5 billion with a P/E ratio of 3.5. Trailing twelve-month revenue increased by 22.3%, and the net margin is 19.1%. The stock has a beta of 0.64 and a 52-week range of $23.62 to $45.45. Over the last eight sessions, the stock moved up 48.8%, rising from $38.50 to $57.29. On October 28, 2026, the stock printed 58 fresh 52-week highs and 2 fresh 52-week lows. Unusual options activity in the last 36 hours included five notable prints, with call premium totaling $5.6 million versus put premium of $298,000. The largest single print was $2.3 million.

What To Watch

Investors will monitor the broader coverage of the Phase III results and any subsequent analyst adjustments to price targets following the clinical update.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

GMAB by the numbers

7 sessions: -5.03%Coverage: 1 stories / 1 sourcesAI sentiment: 74/100 (bullish)Mkt cap: $26.5BP/E: 3.552w: $23.62 to $45.45
GMAB · Oct 29 session (5-min) · -2.01% vs prior close · updated 8:57 PM ET
$55.63$56.87$58.11prev close $57.29$56.147:00 AM9:43 AM12:27 PM3:11 PM5:55 PM7:00 AM · $56.527:05 AM · $56.497:10 AM · $56.327:15 AM · $56.347:25 AM · $56.267:30 AM · $56.297:35 AM · $56.077:40 AM · $56.207:45 AM · $56.557:50 AM · $56.207:55 AM · $56.368:00 AM · $56.348:05 AM · $56.538:10 AM · $56.708:15 AM · $56.648:25 AM · $56.628:30 AM · $56.748:45 AM · $56.558:50 AM · $56.208:55 AM · $56.209:00 AM · $56.169:05 AM · $56.209:10 AM · $56.379:15 AM · $56.499:25 AM · $56.629:30 AM · $57.029:35 AM · $57.749:40 AM · $57.709:45 AM · $57.599:50 AM · $57.989:55 AM · $57.8210:00 AM · $57.5810:05 AM · $57.2110:10 AM · $57.2710:15 AM · $57.1410:20 AM · $56.9510:25 AM · $56.8210:30 AM · $56.7810:35 AM · $56.7710:40 AM · $56.9710:45 AM · $56.8510:50 AM · $56.8010:55 AM · $56.9511:00 AM · $57.0811:05 AM · $56.8811:10 AM · $57.0411:15 AM · $57.4011:20 AM · $57.4911:25 AM · $57.3111:30 AM · $57.3811:35 AM · $57.1411:40 AM · $56.7211:45 AM · $56.6611:50 AM · $56.6611:55 AM · $56.6012:00 PM · $56.5112:05 PM · $56.5012:10 PM · $56.5712:15 PM · $56.4712:20 PM · $56.2812:25 PM · $56.3912:30 PM · $56.1912:35 PM · $56.3612:40 PM · $56.4012:45 PM · $56.3812:50 PM · $56.0212:55 PM · $56.081:00 PM · $56.081:05 PM · $56.131:10 PM · $56.091:15 PM · $56.161:20 PM · $56.111:25 PM · $56.211:30 PM · $56.091:35 PM · $56.191:40 PM · $56.081:45 PM · $56.091:50 PM · $56.131:55 PM · $56.102:00 PM · $56.152:05 PM · $55.852:10 PM · $55.842:15 PM · $55.822:20 PM · $55.792:25 PM · $55.772:30 PM · $55.902:35 PM · $55.862:40 PM · $55.872:45 PM · $55.912:50 PM · $55.892:55 PM · $55.853:00 PM · $55.983:05 PM · $56.013:10 PM · $56.063:15 PM · $56.173:20 PM · $56.163:25 PM · $56.313:30 PM · $56.453:35 PM · $56.453:40 PM · $56.203:45 PM · $56.293:50 PM · $56.343:55 PM · $56.484:00 PM · $56.494:05 PM · $55.814:15 PM · $56.504:35 PM · $56.355:00 PM · $56.605:15 PM · $56.385:25 PM · $55.775:35 PM · $56.495:40 PM · $56.515:55 PM · $56.14
AI sentiment, last 36h · averaged over 1 story · 74/100 bullish
AI sentiment 74/100 (bullish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 1 story on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agonowInvestors.com · sentiment 74 · Genmab's Scores A 'Hat Trick' And Cruises 60% In A Month. What Comes Next.Investors.com · 74Genmab's Scores A 'Hat Trick' And Cruises 60% In A Month. What Comes Next.
4h agoInvestors.comBULLISH 74General

Genmab's Scores A 'Hat Trick' And Cruises 60% In A Month. What Comes Next.

Genmab stock skyrocketed 60% over the course of October on an unexpected "hat trick" in cancer treatment.

Frequently asked questions

Why is GMAB stock moving today?

GENMAB A/S ADR (GMAB) is drawing unusual attention today. Our newswire has captured 1 story on GMAB across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 74/100). The most recent driver: "Genmab's Scores A 'Hat Trick' And Cruises 60% In A Month. What Comes Next." (Investors.com).

Is GMAB a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of GMAB coverage reads 74/100 over 1 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.

More moves explained today

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on GMAB: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier GMAB move explainers: 2026-10-29 · 2026-10-06 · 2026-10-05